Canada
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -1.77 B
|
Dec. 31, 2023 | USD 156.50 | -0.56% |
|
Canada |
|
2 |
USD -1.56 B
|
Dec. 31, 2023 | USD 125.74 | -0.23% |
|
Canada |
|
3 |
USD -428.43 M
|
Sept. 30, 2024 | USD 64.97 | 1.17% |
|
Canada |
|
4 |
USD -97.64 M
|
Dec. 31, 2023 | USD 7.91 | 7.55% |
|
Canada |
|
5 |
USD -89.00 M
|
Dec. 31, 2023 | USD 3.84 | 1.43% |
|
Canada |
|
6 |
USD -77.51 M
|
Dec. 31, 2023 | USD 3.17 | -1.86% |
|
Canada |
|
7 |
USD -48.37 M
|
Dec. 31, 2023 | USD 11.31 | 1.91% |
|
Canada |
|
8 |
USD -22.33 M
|
Dec. 31, 2023 | USD 5.33 | -0.12% |
|
Canada |
|
9 |
USD -19.15 M
|
Dec. 31, 2023 | USD 4.39 | 2.76% |
|
Canada |
|
10 |
USD -16.05 M
|
Dec. 31, 2023 | USD 11.59 | 0.75% |
|
Canada |
|
11 |
USD -7.51 M
|
Dec. 31, 2023 | USD 4.00 | 3.39% |
|
Canada |
|
12 |
USD -6.99 M
|
Oct. 31, 2024 | USD 2.82 | 1.40% |
|
Canada |
|
13 |
USD -6.56 M
|
Dec. 31, 2023 | USD 1.59 | 1.49% |
|
Canada |
|
14 |
USD -5.62 M
|
Dec. 31, 2023 | USD 39.98 | -1.21% |
|
Canada |
|
15 |
USD -4.08 M
|
Dec. 31, 2023 | USD 14.60 | -0.95% |
|
Canada |
|
16 |
USD -1.94 M
|
Dec. 31, 2023 | USD 1.22 | 2.52% |
|
Canada |
|
17 |
USD -1.82 M
|
Nov. 30, 2023 | USD 1.52 | 2.02% |
|
Canada |
|
18 |
USD -925.00 K
|
Oct. 31, 2024 | USD 6.90 | 1.77% |
|
Canada |
|
19 |
USD -718.00 K
|
Dec. 31, 2023 | USD 7.95 | -0.62% |
|
Canada |
|
20 |
USD -456.80 K
|
July 31, 2024 | USD 4.53 | 8.70% |
|
Canada |
|
21 |
USD -266.00 K
|
March 31, 2024 | USD 2.65 | -1.93% |
|
Canada |
|
22 |
USD -189.00 K
|
Dec. 31, 2023 | USD 2.96 | 1.10% |
|
Canada |
|
23 |
USD -169.61 K
|
Aug. 31, 2023 | USD 1.86 | 5.08% |
|
Canada |
|
24 |
USD -148.65 K
|
June 30, 2024 | NA |
|
Canada |
||
25 |
USD -144.00 K
|
Dec. 31, 2023 | USD 9.51 | -0.80% |
|
Canada |
|
26 |
USD -133.55 K
|
Dec. 31, 2023 | USD 0.15 | -5.56% |
|
Canada |
|
27 |
USD -112.00 K
|
Dec. 31, 2023 | USD 1.97 | -2.48% |
|
Canada |
|
28 |
USD -106.69 K
|
Dec. 31, 2023 | USD 2.04 | -0.20% |
|
Canada |
|
29 |
USD -55.36 K
|
Dec. 31, 2023 | USD 3.07 | -0.98% |
|
Canada |
|
30 |
USD -47.11 K
|
Dec. 31, 2023 | USD 0.89 | -2.92% |
|
Canada |
|
31 |
USD -6.04 K
|
Dec. 31, 2023 | USD 0.73 | 3.09% |
|
Canada |
|
32 |
USD -48.52
|
Dec. 31, 2023 | USD 1.45 | 3.65% |
|
Canada |
|
33 |
USD 0.00
|
Sept. 30, 2024 | USD 1.91 | 1.06% |
|
Canada |
|
34 |
USD 0.00
|
Sept. 30, 2024 | USD 1.72 | 2.38% |
|
Canada |
|
35 |
USD 0.00
|
Dec. 31, 2023 | USD 6.23 | -0.19% |
|
Canada |
|
36 |
USD 0.00
|
July 31, 2024 | USD 1.49 | 8.76% |
|
Canada |
|
37 |
USD 0.00
|
Dec. 31, 2023 | USD 6.79 | -4.77% |
|
Canada |
The Healthcare company in Canada with the highest Capital Expenditure is George Weston Limited (Toronto Stock Exchange: WN.TO) at USD -1.77 B.
The Healthcare company in Canada with the lowest Capital Expenditure is Mind Medicine (MindMed) Inc. (NasdaqGS: MNMD) at USD 0.00.
The top 10 Healthcare companies in Canada by Capital Expenditure are George Weston Limited, Loblaw Companies Limited, Metro Inc., Extendicare Inc., TELUS International (Cda) Inc., AbCellera Biologics Inc., Sienna Senior Living Inc., dentalcorp Holdings Ltd., WELL Health Technologies Corp. and Medical Facilities Corporation.
The bottom 10 Healthcare companies in Canada by Capital Expenditure are Mind Medicine (MindMed) Inc., Clearmind Medicine Inc., Profound Medical Corp., ESSA Pharma Inc., Edesa Biotech, Inc., Cardiol Therapeutics Inc., Oncolytics Biotech Inc., XORTX Therapeutics Inc., Eupraxia Pharmaceuticals Inc. and NervGen Pharma Corp..